Edison Investment Research - IFA Systems AG (IS8) Termination of coverage

Report

Edison Investment Research

Termination of coverage

Edison Investment Research is terminating coverage on Ifa Systems (IS8). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

11/04/2017 1 EN

Underlying

IFA Systems AG

IFA Systems is an information technology group based in Germany. Co. is engaged in offering IT solutions for eye care specialists worldwide. Co.'s IT product range includes: EMR (electronic medical records); scheduling; workflow management; quality management; and over 450 interface modules connecting the complete instrument and equipment network of eye care hospitals, clinics and practices. Co.'s service offering includes consulting, system integration, training and hotline. Co. offers software and quality management systems in English, German, Spanish, Portuguese, Italian, Finnish and Flemish.

See profile

DE0007830788 Germany

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Other Reports on these Companies

SmartInsider

Ifa Systems Ag: 1 director

A director at Ifa Systems Ag sold 7,754 shares at 4.480EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Free Trial

December 2, 2022 December 2, 2022 1 EN

BankM AG

Digitalisierung im Gesundheitswesen ist Garant für zukünftiges Wachstum

MiFID II – Hinweis: Diese Studie wurde auf Grundlage einer vertraglichen Vereinbarung im Auftrag des Emittenten erstellt und von diesem vergütet. Die Studie wurde gleichzeitig allen Interessenten öffentlich zugänglich gemacht. Der Erhalt dieser Studie gilt somit als zulässiger geringfügiger nichtmonetärer Vorteil im Sinne des § 64 Abs. 7 Satz 2 Nr. 1 und 2 des WpHG. Glänzendes Geschäftsergebnis 2020 der ifa systems AG (ISIN DE0007830788, Basic Board, IS8 GR) unter Berücksichtigung der durchgeführten Akquisition und dem Sondereffekt im vergangenen Gj. 2020. Sowohl im 1. als auch im 2. Semes...

May 5, 2021 May 5, 2021 17 DE

EQS Group AG

DGAP-News: ifa systems AG: ifa systems schließt 2020 erfolgreich ab

DGAP-News: ifa systems AG / Schlagwort(e): Jahresergebnis/Jahresbericht ifa systems AG: ifa systems schließt 2020 erfolgreich ab 05.03.2021 / 07:55 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Umsatz mit 7,3 Mio. € leicht oberhalb der geplanten Spanne, EBIT mit 0,3 Mio. € innerhalb der Ziele Einfluss der Corona-Pandemie geringer als erwartet Mit Sophrona für 2021 deutliches Wachstum geplant Die ifa systems AG (ISIN DE0007830788), ein führendes weltweit tätiges Software-Unternehmen, das sich auf die Augenheilkunde (Ophthalmologie) spezial...

March 5, 2021 March 5, 2021 1 DE

Norcros - Sale of Johnson Tiles UK agreed

Norcros’s disposal of Johnson Tiles is the latest strategic activity taken by management to better allocate capital to fit with priorities. Last year it closed its UK adhesives operation. Norcros has a compelling investment case, where its new product development initiatives, market positioning and self-help initiatives allow it to take market share in both the UK and South Africa. Its rating is low at 6.0x FY24e P/E, which is attractive, especially when compared to its yield of 5.4% on its well-covered dividend. We retain our estimates and value the shares at 246p, implying c 30% upside.

13h / 3m 13h / 3m 1 EN

Pedro Fonseca

Pedro Fonseca

Henderson Far East Income - Repositioning to raise total returns

Henderson Far East Income (HFEL) has consistently delivered on its objective to provide a rising dividend. However, like many investors, HFEL’s managers overestimated the potential for a post-pandemic rebound in China. The trust’s resultant overweight to Chinese consumer and other cyclicals led to a fall in portfolio revenues and underperformance in the financial year ended 31 August 2023 (FY23). With a view to improving future returns, HFEL’s board has since indicated an increased willingness to use reserves when necessary to support dividend payments, which it did in FY23. This reduces the r...

15h / 53m 15h / 53m 1 EN

Richard Williamson

Richard Williamson

Freelancer - AI to drive return to growth

Freelancer’s Q124 results were mixed. Operationally, the company is seeing rising demand for AI specialists as customers seek affordable ways to develop proprietary AI. Notably, in Enterprise, the company delivered a large-scale AI pilot for a tech giant, sourcing 20,000 freelancers in 24 hours across 52 languages. This impressive achievement could lead to a substantial multi-year contract. Major initiatives across Loadshift and Escrow with leading organisations are set to be deployed over the coming months, potentially catalysing performance and diversifying revenue streams. We revise our for...

16h / 55m 16h / 55m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN